His question makes no sense (he has me on Ignore so I'll respond here). How could NP be referring to the drug causing a bad response in some patients when the trial is blinded? He has no way of knowing who got Leronlimab and who didn't. LGTC has a long history of sewing doubt with his posts, and this is why so many of us are very leery of him.
"Is he saying the drug caused a bad response in some patients resulting in death"
Read More:
https://investorshangout.com/post/view?id=581...z6Qxoa0fnN